Quarterhill Inc. (QTRH:CA) Q4 2025 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call highlights improving margins, positive adjusted EBITDA, and a successful multiyear transformation, all indicating a stronger operational foundation. The strategic outlook for 2026 is optimistic with growing demand for technology solutions. Despite acknowledging risks and the non-standardized nature of adjusted EBITDA, the overall sentiment is positive. The lack of shareholder return discussion is a minor negative, but not enough to outweigh the positives. Hence, a positive stock price movement of 2% to 8% is expected over the next two weeks.
Key Financial Performance
Adjusted EBITDA Positive adjusted EBITDA, indicating improvement in profitability. Reasons for change include a multiyear transformation to stabilize the business and improve execution and discipline.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
Improving Margins: Quarterhill is operating from a stronger foundation with improving margins.
Positive Adjusted EBITDA: Quarterhill has achieved positive adjusted EBITDA.
Multiyear Transformation: Quarterhill has been executing a multiyear transformation to stabilize the business, improve execution, discipline, and return the company to sustainable profitability.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Risks related to forward-looking statements: The company acknowledges that actual results could differ materially from anticipated outcomes due to various risk factors. These risks are detailed in the company's annual information form and other public filings.
Non-standardized financial measures: The use of adjusted EBITDA, which does not have a standardized meaning prescribed by IFRS, could lead to challenges in financial interpretation and comparison.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Multiyear Transformation: Quarterhill has been executing a multiyear transformation to stabilize the business, improve execution, discipline and return the company to sustainable profitability.
2026 Outlook: As we enter 2026, Quarterhill is operating from a stronger foundation with improving margins, positive adjusted EBITDA and growing demand for our technology solutions. We are also seeing strong demand across our markets.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:Review of Unclear Management Responses
A:
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
CEO Director
Chief Executive
Conference today
Cormark Securities
Director Chief
EDT Gavin
Executive Officer
Fairweather Cormark
Financial Results
Full Financial
Gavin Fairweather
IFRS MDA
Inc Full
Instructions news
MDA note
MDA statement
Officer EDT
Officer Instructions
Risk factor
SEDAR conference
SEDAR matter
Securities Inc
conference meaning
conference response
dollar Mr
factor risk
filing SEDAR
form filing
information dollar
information form
matter today
meaning IFRS
measure information
news release
note use
question statement
release MDA
response question
NRXP Transcript
NRx Pharmaceuticals, Inc. (NRXP) Q1 2026 Earnings Call Transcript
Unknown5-18
The earnings call presents mixed signals. The financial performance shows a significant reduction in net loss, which is positive, but rising operational costs and reliance on cash resources pose concerns. The Q&A section reveals uncertainties in regulatory approval processes and supply chain issues, but the company's strategic initiatives and FDA engagement offer some optimism. Overall, the sentiment is neutral, as positive and negative factors balance each other out.
NRx Pharmaceuticals, Inc. (NRXP) Q4 2025 Earnings Call Transcript
Positive3-24
The earnings call summary shows strong financial performance with a 25% revenue increase and a shift to net income from a previous loss, indicating improved profitability. Operating expenses decreased, and cash flow improved significantly. Despite risks associated with forward-looking statements, the financial health and strategic initiatives like clinic expansion and drug development are promising. The absence of negative sentiment in the Q&A further supports a positive outlook. Given these factors, the stock price is likely to experience a positive movement over the next two weeks.
Quarterhill Inc. (QTRH:CA) Q4 2025 Earnings Call Transcript
Positive3-23
The earnings call highlights improving margins, positive adjusted EBITDA, and a successful multiyear transformation, all indicating a stronger operational foundation. The strategic outlook for 2026 is optimistic with growing demand for technology solutions. Despite acknowledging risks and the non-standardized nature of adjusted EBITDA, the overall sentiment is positive. The lack of shareholder return discussion is a minor negative, but not enough to outweigh the positives. Hence, a positive stock price movement of 2% to 8% is expected over the next two weeks.
NRx Pharmaceuticals, Inc. (NRXP) Q3 2025 Earnings Call Transcript
Unknown11-17
The company's financial performance shows increased losses and limited revenue, but it has a stronger cash position. The strategic plan highlights promising drug developments and market opportunities, yet faces significant market, operational, and scientific risks. The Q&A session reveals some optimism about regulatory paths but also uncertainty and vague responses. Overall, the mixed signals suggest a neutral sentiment, with potential for both positive and negative developments.
NRXP Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
